162.53
1
[1]. Stangier J, et al. Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment. J Clin Pharmacol. 2008 Dec;8(12):111-.
H302-H315-H31-H335
P261-P26-P270-P271-P280-P302+P352-P30+P30-P330-P362+P36-P05-P501